Tag: virus-based therapeutics
Former CIO and Treasurer to Mayo Clinic, Harry Hoffman named to Vyriad, Inc. Board of Directors
eNewsChannels NEWS: -- yriad, Inc., a clinical-stage biotechnology company developing oncolytic virus therapies to treat a wide range of cancers, today announced the appointment of leading life sciences investor Harry Hoffman to the Company's board of directors.
